StockWatch
·

TRANSGENE BIOTEK LTD. Q1 FY27 Results

TRABIQ1 FY27 Results
Filing
Result:Poor· Market: Flat
MetricValue ( Cr)Q4 FY26Q1 FY26
Revenue0.0610.1%21.2%
Total Income0.0670.7%21.2%
Expenditure0.4532.1%7.1%
PBT-0.3914.9%10.3%
Net Profit-0.3914.9%10.3%
OPM-97.00%
NPM
EPS0.0516.7%16.7%
View full financials

Healthcare micro-cap remains deeply loss-making with negligible revenue (₹0.06cr) and negative margins, a marginally smaller loss YoY does not offset continued deterioration and absence of a real turnaround.

Informational and educational content only. Not investment advice.